In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flexin continus Drug Master File in Korea (Flexin continus KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flexin continus. The MFDS reviews the Flexin continus KDMF as part of the drug registration process and uses the information provided in the Flexin continus KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flexin continus KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flexin continus API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flexin continus suppliers with KDMF on PharmaCompass.